Search Results - "Grytli, H.H"

Non-selective beta-blocker use is associated with reduced cancer recurrence after radical prostatectomy: A prospective cohort study on 11256 radically operated patients by Sivanesan, S., Taskén, K.A., Grytli, H.H.

Get full text

Total beta-blocker treatment delays development of castration resistance in prostate cancer xenograft models by Hagberg Thulin, M., Ramberg, H.K., Sivanesan, S., Nielsen, H.K., Guldvik, I.J., Grytli, H.H., Tasken, K.A.

Get full text

UP52 - Total beta-blocker treatment delays development of castration resistance in prostate cancer xenograft models by Hagberg Thulin, M., Ramberg, H.K., Sivanesan, S., Nielsen, H.K., Guldvik, I.J., Grytli, H.H., Tasken, K.A.

Get full text

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence by Braadland, P.R, Giskeødegård, G, Guldvik, I.J, Sandsmark, E, Bertilsson, H, Euceda, L, Hansen, A, Grytli, H.H, Katz, B, Svindland, A, Berge, V, Eri, L.M, Nygård, S, Bathen, T, Tasken, K.A, Tessem, M.-B

Get full text

Beta-blockers reduce post-castration tumor growth in prostate cancer xenograft models by Nielsen, H.K., Thulin, M.H., Ramberg, H., Waagene, S., Kristian, A., Mælandsmo, G.M., Levy, F.O., Persson, E., Taskén, K.A., Grytli, H.H.

Get full text

P-50 - Beta-blockers reduce post-castration tumor growth in prostate cancer xenograft models by Nielsen, H.K., Thulin, M.H., Ramberg, H., Waagene, S., Kristian, A., Mælandsmo, G.M., Levy, F.O., Persson, E., Taskén, K.A., Grytli, H.H.

Get full text